Asimov

(Senior) Business Development Manager

Remote

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Synthetic BiologyIndustries

Job Description

Position Overview

Asimov is seeking a (Senior) Business Development Manager to join its fast-growing Commercial team. This role focuses on taking ownership of one of Asimov's core territories (Mid-Atlantic or Southwest U.S.). It is a senior individual contributor position emphasizing leadership, autonomy, and strategic ownership without a traditional management hierarchy. While there are no direct reports initially, success is measured by individual performance and the ability to collaborate across teams to achieve collective goals.

Asimov's mission is to advance humanity's ability to design living systems, enabling biotechnologies with outsized benefit to society. We are developing a mammalian synthetic biology platform––from cells to software––to enable the design and manufacture of next-generation therapeutics.

We are looking for a hands-on, results-driven professional who thrives in a fast-paced, dynamic environment and is eager to make an immediate impact on Asimov’s commercial growth and strategy.

Responsibilities

  • Develop and execute territory growth strategies to drive revenue, expand market presence, and position Asimov within the broader biopharma ecosystem, while actively collaborating across the Business Development team.
  • Identify, develop, and close new business opportunities with biopharma companies ranging from venture-backed startups to emerging commercial-stage players.
  • Own the commercial deal process, shaping partnership strategy and driving alignment on terms, proposals, and agreements to achieve territory and organizational goals.
  • Contribute to our culture of openness, growth, and collaboration, modeling initiative, mutual support, and team-oriented success.
  • Represent Asimov externally at key conferences, meetings, and industry events to raise visibility, build relationships, and strengthen our reputation in the field.
  • Contribute to team success by sharing insights, supporting peers, and reinforcing a culture of accountability and shared learning.

Requirements

  • Experience:
    • 5+ years of commercial experience within biotech, CDMO/CRO services, or life sciences tools.
    • 10 years of overall experience in the biotech or life sciences industry.
  • Skills & Knowledge:
    • Track record of selling bespoke technical services, especially where strategy and creativity were key to customer engagement.
    • Deep understanding of CMC, process development, and manufacturing of biologics and/or viral vectors.
    • Ability to navigate complex sales cycles, balancing client priorities with internal capabilities and capacity.
    • Strong communication and relationship-building skills, both internally and externally.
  • Education:
    • A scientific or technical background in life sciences (e.g., bioengineering, molecular biology, biochemistry).
    • Advanced degrees (MBA, MS, PhD) are welcome but not required.

Employment Type

  • Full-time

Location Type

  • Not Specified

Salary

  • Not Specified

Company Information

Asimov is fueled by a vision to transform biological engineering into a fully-fledged engineering discipline. Joining our team means growing with a constantly evolving organization and pushing the frontiers of synthetic biology. Company culture is key to Asimov, and ours is a culture of recombination; we believe that our mission can only be achieved by bringing together a diverse team with a mixture of backgrounds and perspectives.

Application Instructions

  • Not Specified

Skills

Business Development
Sales
Biopharma
Synthetic Biology
Partnership Strategy
Deal Negotiation
Market Expansion
Relationship Building
Strategic Planning

Asimov

Synthetic biology solutions for biopharmaceuticals

About Asimov

Asimov operates in the synthetic biology field, providing a combination of cells, genes, and software to assist in advanced genetic design. Their products include cloud-based software that allows clients in the biopharmaceutical industry to design, simulate, and optimize genetic systems. Additionally, they offer engineered GMP host cells that are used for therapeutic applications. Asimov distinguishes itself from competitors by guaranteeing high titer cell lines for monoclonal antibodies with a promise of '4 g/L or it's free,' which reduces risk for their clients. The company's goal is to enable biopharma companies to produce high-quality protein therapeutics and scalable viral vectors efficiently, supported by their in-house expertise in synthetic biology and process development.

Boston, MassachusettsHeadquarters
2017Year Founded
$199.1MTotal Funding
SERIES_BCompany Stage
AI & Machine Learning, BiotechnologyIndustries
51-200Employees

Risks

Competition from LatchBio's code-free biocomputing infrastructure challenges Asimov's software offerings.
Integration of The Foundry may lead to potential cultural clashes and operational disruptions.
Rapid data generation in synthetic biology may strain Asimov's data processing capabilities.

Differentiation

Asimov offers a '4 g/L or it's free' promise for monoclonal antibodies.
The LV Edge Producer System eliminates GMP plasmid costs and reduces process complexity.
Asimov integrates synthetic biology, computer-aided design, and machine learning for genetic design.

Upsides

Stable cell line development reduces costs and increases scalability in lentiviral production.
Acquisition of The Foundry enhances Asimov's expertise in genetic design and engineering.
Growing biotech investments indicate a robust market for Asimov's engineered cell lines.

Land your dream remote job 3x faster with AI